Abstract: Sanofi-aventis, the largest pharmaceutical company in Europe and the fourth-largest in the world, began a partnership with the World Health Organization in 2001 to fight sleeping sickness and other neglected diseases affecting the world’s poorest people. Initial discussions with the World Health Organization showed that a simple drug donation was not enough. Only combined action—drug donation, subsidies to fund distribution programmes and new research and development to improve treatments and diagnostics—could create a reasonable chance to bring sleeping sickness back under control. Over the first five years, 36 African countries benefited from the partnership. Click here to read more…
